The University of Texas at Arlington

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 2014-01-01

Employees: 5K

Market Cap: -

Website: http://www.uta.edu

Clinical Trials

The Effect of Antioxidants on Skin Blood Flow During Local Heating

Phase 1

Completed

Conditions: Cardiovascular Diseases
Vasodilation
Cardiovascular Risk Factor

Interventions: Drug: Apocynin
Drug: Allopurinol
Other: Control (Lactated Ringer's)
Drug: Tempol

First Posted Date: 2018-09-21

Last Posted Date: 2018-09-21

Lead Sponsor: The University of Texas at Arlington

Target Recruit Count: 44

Registration Number: NCT03680638

Locations: 🇺🇸
Engineering Research Building, Arlington, Texas, United States

The Effect of Antioxidants on Skin Blood Flow-BH4

Phase 1

Completed

Conditions: Cardiovascular Diseases
Cardiovascular Risk Factor
Vasoconstriction

Interventions: Drug: NG Nitro L Arginine Methyl Ester
Drug: Apocynin
Drug: BH4
Drug: Allopurinol
Drug: Sodium Nitroprusside
Drug: Acetyl-ß-methylcholine chloride

First Posted Date: 2018-09-21

Last Posted Date: 2018-09-26

Lead Sponsor: The University of Texas at Arlington

Target Recruit Count: 16

Registration Number: NCT03680573

Locations: 🇺🇸
Engineering Research Building, Arlington, Texas, United States

The Effect of Local Antioxidant Therapy on Racial Differences in Vasoconstriction

Phase 1

Completed

Conditions: Cardiovascular Risk Factor
Cardiovascular Diseases
Vasoconstriction

Interventions: Drug: Control (Phenylephrine)
Drug: Phenylephrine + Tempol
Drug: Phenylephrine + Allopurinol
Drug: Phenylephrine + Apocynin

First Posted Date: 2018-09-21

Last Posted Date: 2020-11-05

Lead Sponsor: The University of Texas at Arlington

Target Recruit Count: 24

Registration Number: NCT03680404

Locations: 🇺🇸
Science and Engineering Research and Innovation Building, Arlington, Texas, United States

The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction

Phase 1

Completed

Conditions: Cardiovascular Diseases
Cardiovascular Risk Factor
Vasoconstriction

Interventions: Drug: NG Nitro L Arginine Methyl Ester
Drug: BQ-123
Drug: BQ-788
Drug: L-Arginine
Drug: Sodium Nitroprusside
Drug: Lactated Ringer's

First Posted Date: 2018-09-20

Last Posted Date: 2024-06-11

Lead Sponsor: The University of Texas at Arlington

Target Recruit Count: 19

Registration Number: NCT03679780

Locations: 🇺🇸
Science and Engineering Research and Innovation Building, Arlington, Texas, United States

The Senior Companion Program Plus

Not Applicable

Completed

Conditions: Family
Alzheimer Dementia

Interventions: Behavioral: SCP Plus

First Posted Date: 2018-07-26

Last Posted Date: 2024-10-01

Lead Sponsor: The University of Texas at Arlington

Target Recruit Count: 20

Registration Number: NCT03602391

Locations: 🇺🇸
The Senior Source, Dallas, Texas, United States

Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

Phase 4

Recruiting

Conditions: Chronic Kidney Diseases

Interventions: Other: Placebo
Drug: Pioglitazone

First Posted Date: 2018-03-20

Last Posted Date: 2024-05-23

Lead Sponsor: The University of Texas at Arlington

Target Recruit Count: 28

Registration Number: NCT03471117

Locations: 🇺🇸
UT Southwestern, Dallas, Texas, United States
🇺🇸
University of Texas at Arlington, Arlington, Texas, United States

Transcranial Infrared Laser Stimulation (TILS) of Prefrontal Cognition in Post-traumatic Stress Disorder (PTSD)

Not Applicable

Terminated

Conditions: Post-traumatic Stress Disorder (PTSD)

Interventions: Device: TILS
Device: sham

First Posted Date: 2017-07-06

Last Posted Date: 2021-07-23

Lead Sponsor: The University of Texas at Arlington

Target Recruit Count: 10

Registration Number: NCT03209882

Locations: 🇺🇸
Engineering Research Building (ERB), University of Texas Arlington, Arlington, Texas, United States

Mechanisms and Management of Exercise Intolerance in Older Heart Failure Patients

Not Applicable

Completed

Conditions: Heart Failure, Diastolic

Interventions: Other: Exercise Training

First Posted Date: 2017-04-12

Last Posted Date: 2020-03-03

Lead Sponsor: The University of Texas at Arlington

Target Recruit Count: 12

Registration Number: NCT03111017

Locations: 🇺🇸
University of Texas at Arlington, Arlington, Texas, United States

METRIC: Measurement, Education and Tracking in Integrated Care

Not Applicable

Completed

Conditions: Depression

Interventions: Other: Measurement-Based Integrated Care
Behavioral: Standard Education
Behavioral: Depression Education Fotonovela

First Posted Date: 2016-03-08

Last Posted Date: 2023-05-19

Lead Sponsor: The University of Texas at Arlington

Target Recruit Count: 150

Registration Number: NCT02702596

DESEO: DEpression Screening and Education: Options to Reduce Barriers to Treatment

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Depression Education Intervention

First Posted Date: 2015-07-07

Last Posted Date: 2018-07-10

Lead Sponsor: The University of Texas at Arlington

Target Recruit Count: 350

Registration Number: NCT02491034

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy